A class 1 medical device (as reviewed by Health Canada’s Bureau of Device Licensing) that absorbs infectious viruses including coronavirus, influenza, common cold, and RSV. As virus lingers in the nose prior to entering the body, the Nosebrush can absorb that virus, reducing the viral load. Less viral load, less illness. The absorptive material does not contain chemicals. Patent pending.

Founder/Inventor Steven Moss MD, FRCP, Dip. ABP, Associate Professor, University of Toronto has been a member of H2i since 2017 and is member of the Ontario Bioscience Innovation Organization. Nosebrush has a dedicated team of legal, business, regulatory, marketing, and distribution individuals.

The Nosebrush is distributed to Rexall and Amazon by Norrizon.

Contact Info: